Patent · US Active

Bradykinin B1-receptor antagonists

US8450306B2 · kind B2 · utility

3Cited by
1References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 12, 2008
Grant dateMay 28, 2013
Priority date
Expiry dateOct 25, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2602/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel compounds which are useful for treating acute pain, visceral pain, neuropathic pain, inflammatory/pain receptor-mediated pain, tumor pain and headache diseases. The following is exemplary:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.